Complix NV
Technologiepark 94
9052 Zwijnaarde
BE
Complix NV
Foundation date
23/06/2008
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Cardiovascular
- #Diseases of the blood and blood-forming organs - immune disorders
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
Complix is a biopharmaceutical company engaged in the discovery and development of Alphabodies™, a revolutionary class of biopharmaceuticals with exceptional properties. Alphabodies™ combine beneficial properties of small molecules with those of antibodies, and can address intracellular as well as extracellular disease targets that are undruggable by antibodies or small chemical drugs. Complix has developed a balanced pipeline of transformative protein therapeutics in oncology, autoimmunity/inflammation and viral diseases.
Upcoming events
All events-
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona -
3005 '24
Recent insights into Immuno-Oncology (2nd edition)
Event by: VIB -
1306 '24
Spatial Omics
Event by: VIB
Latest news
More news-
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
Friday May 17th 2024
Read more
-
20 years of progress: flanders.bio and VIB put biotech and life sciences in spotlight
Wednesday May 15th 2024
Read more
-
Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®
Monday May 13th 2024
Read more
Jobs
More jobs-
18/05/24
Flemish Brabant
Personal Assistant @ Lab of Angiogenesis and Vascular Metabolism
Permanent
VIB -
-
15/05/24
Flemish Brabant
LISCO Innovation Lab - Biostatistician (Postdoc position) (ref. BAP-2024-307)
Postdoc
KU Leuven
More info?
Ellen Telleir
Communication Coordinator